IP Library Granted Patent US 11,771,891
Granted Patent B2
US 11,771,891 · App. 17/338,754 · Granted Oct 3, 2023

Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain

Inventors: Joseph W. Boggs (Chapel Hill, NC); Rosemary H. Zang (Avon Lake, OH)
Assignee: SPR THERAPEUTICS, INC.
A61N1/0551A61N1/0456A61N1/0502A61N1/0558A61N1/36021A61N1/36071A61B5/061A61N1/36017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,891
App. No.
17/338,754
Granted
Oct 3, 2023
Kind
B2
Abstract

Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt, such as in a case of post-amputation residual limb pain, or purportedly felt in the case of post-amputation phantom limb pain.

Claims (19)

1. A stimulation system comprising:

a coiled fine wire lead having a thickness and a diameter configured for percutaneous insertion into a portion of a body;

a plurality of electrodes each formed integrally on the coiled fine wire lead, wherein the electrodes are spaced apart from one another with an insulated portion positioned between at least two of the plurality of electrodes; and

an electrical stimulation device operatively coupled to the coiled fine wire lead and configured to apply electrical stimulation through the plurality of electrodes, wherein the electrodes are configured to be positioned in tissue a distance spaced from (i) at least one of a Type Ia and Ib afferent nerve fibers and (ii) at least one of Type III and Type IV nerve fibers and wherein the electrical stimulation selectively activates at least one of the Type Ia and Ib afferent nerve fibers while minimizing recruitment of activation of the at least one of the Type III and Type IV nerve fibers because the plurality of electrodes are spaced the distance from the at least one of a Type Ia and Ib afferent nerve fibers and the at least one of Type III and Type IV nerve fibers.

2. The stimulation system of claim 1 , wherein the electrical stimulation device comprises an external pulse generator.

3. A stimulation system comprising:

a coiled fine wire lead configured for percutaneous insertion into a body, wherein the coiled fine wire lead comprises a plurality of electrodes each formed integrally on the coiled fine wire lead, wherein the electrodes are spaced apart from one another with an insulated portion positioned between at least two of the plurality of electrodes; and

an electrical stimulation device operatively coupled with the coiled fine wire lead, wherein the electrical stimulation device is configured to deliver electrical stimulation through the plurality of electrodes to a neural fiber bundle within a body, wherein the plurality of electrodes are configured to be positioned in tissue in electrical proximity to but spaced away from the neural fiber bundle, wherein the neural fiber bundle comprises at least one of a Type Ia and Ib afferent nerve fiber and an efferent nerve fiber and wherein the at least one of Type Ia and Ib afferent nerve fiber of the neural fiber bundle are selectively activated while minimizing recruitment of activation of the efferent nerve fiber of the neural fiber bundle because the electrode is in electrical proximity but spaced away from the neural fiber bundle to reduce a perception of pain.

4. The stimulation system of claim 3 , wherein selectively activating at least one of the Type Ia and Ib afferent nerve fibers includes selectively activating both of the Type Ia and Ib afferent nerve fibers.

5. The stimulation system of claim 3 , wherein minimizing recruitment of activation includes minimizing recruitment of activation of at least one of a Type III and Type IV nerve fiber of the neural fiber bundle.

6. The stimulation system of claim 3 , wherein minimizing recruitment of activation includes minimizing recruitment of activation of both the Type III and Type IV nerve fibers of the neural fiber bundle.

7. The stimulation system of claim 3 , wherein the electrical proximity to but spaced away from the neural fiber bundle comprises 0.5 to 3 cm from the neural fiber bundle.

8. The stimulation system of claim 3 , wherein the electrical stimulation device comprises an external pulse generator.

9. A stimulation system comprising:

a coiled fine wire lead comprising at least two electrodes, wherein the at least two electrodes are spaced apart from one another with an insulated portion positioned between them and wherein the electrodes are configured to be positioned at a therapeutically effective distance from a neural fiber bundle within tissue, wherein the neural fiber bundle comprises more than one type of nerve fiber;

an electrical stimulation device operatively coupled with coiled fine wire lead, the electrical stimulation device configured to deliver electrical stimulation from the electrodes to the neural fiber bundle, wherein the plurality of electrodes are configured to be positioned in tissue in electrical proximity to but spaced away from the neural fiber bundle, wherein the neural fiber bundle comprises at least one of a Type Ia and Ib afferent nerve fiber and an efferent nerve fiber and wherein the at least one of Type Ia and Ib afferent nerve fiber of the neural fiber bundle are selectively activated while minimizing recruitment of activation of the efferent nerve fiber of the neural fiber bundle because the electrode is in electrical proximity but spaced away from the neural fiber bundle to reduce a perception of pain.

10. The stimulation system of claim 9 , wherein the electrical stimulation evokes paresthesia in a region of pain, wherein the region of pain is spaced from the electrodes.

11. The stimulation system of claim 10 further comprising an introducer needle, wherein the electrodes are placed using the introducer needle percutaneously inserted into the tissue.

12. The stimulation system of claim 9 , wherein the electrical stimulation device comprises an external pulse generator.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2021
From: BOGGS, JOSEPH W.; ZANG, ROSEMARY H.
To: SPR THERAPEUTICS, INC.
Reel/Frame 056436/0458 →